Niki BioSolutions, Inc. (NIKI)
Develops drug candidates to treat cancer and bacterial infections using repurposed molecules.
$8.76+0.04%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-36.1%
The outlook
NIKI is trading near the lower end of its 52-week range, sitting just 7% above its low. The stock shows mixed positioning relative to its moving averages, and analyst coverage leans bearish overall. The data reflects weakness in recent performance rather than momentum.
What’s behind the score
Price trendMixed vs its moving averages
52-week range7% of the way from its 52-week low to high
Market cap
$7.1M
52-wk high
$44.70
52-wk low
$6.00
50-day avg
$8.64
200-day avg
$10.37
Trailing P/E
—